ICU Medical VP Richard Costello Sells 12,187 Shares (ICUI)
ICU Medical (NASDAQ:ICUI) VP Richard Costello unloaded 12,187 shares of the stock in a transaction dated Friday, October 25th. The shares were sold at an average price of $63.16, for a total value of $769,730.92. Following the transaction, the vice president now directly owns 4,707 shares in the company, valued at approximately $297,294. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
Several analysts have recently commented on the stock. Analysts at Roth Capital cut their price target on shares of ICU Medical from $75.00 to $66.00 in a research note to investors on Tuesday. They now have a “neutral” rating on the stock. Separately, analysts at Zacks downgraded shares of ICU Medical from a “neutral” rating to an “underperform” rating in a research note to investors on Monday. They now have a $63.70 price target on the stock. Finally, analysts at Zacks upgraded shares of ICU Medical from an “underperform” rating to a “neutral” rating in a research note to investors on Wednesday, September 18th. They now have a $70.80 price target on the stock. One investment analyst has rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $67.94.
ICU Medical (NASDAQ:ICUI) traded down 1.32% during mid-day trading on Friday, hitting $62.82. 198,045 shares of the company’s stock traded hands. ICU Medical has a 1-year low of $53.01 and a 1-year high of $85.00. The stock’s 50-day moving average is $71.44 and its 200-day moving average is $67.09. The company has a market cap of $925.2 million and a price-to-earnings ratio of 24.43.
ICU Medical (NASDAQ:ICUI) last issued its quarterly earnings data on Monday, October 21st. The company reported $0.72 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.67 by $0.05. The company had revenue of $82.82 million for the quarter, compared to the consensus estimate of $82.64 million. During the same quarter in the previous year, the company posted $0.82 earnings per share. The company’s revenue for the quarter was up 1.7% on a year-over-year basis.
Manufactures custom-made IV products, such as a click-lock positive connection device, and its accessories.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.